326.25

+1.37%↑

TJX

161.61

+0.19%↑

LOW

235.26

+1.64%↑

ROST

220.93

+0.46%↑

AZO

3,438.06

+1.18%↑

326.25

+1.37%↑

TJX

161.61

+0.19%↑

LOW

235.26

+1.64%↑

ROST

220.93

+0.46%↑

AZO

3,438.06

+1.18%↑

326.25

+1.37%↑

TJX

161.61

+0.19%↑

LOW

235.26

+1.64%↑

ROST

220.93

+0.46%↑

AZO

3,438.06

+1.18%↑

326.25

+1.37%↑

TJX

161.61

+0.19%↑

LOW

235.26

+1.64%↑

ROST

220.93

+0.46%↑

AZO

3,438.06

+1.18%↑

326.25

+1.37%↑

TJX

161.61

+0.19%↑

LOW

235.26

+1.64%↑

ROST

220.93

+0.46%↑

AZO

3,438.06

+1.18%↑

Home・Aandelen Lijst・Vestis Corp

Vestis Corp

Gesloten

SectorConsumenten cyclisch

7.79 -0.38

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

7.62

Max

7.83

Belangrijke statistieken
By Trading Economics
Inkomsten	6.2M -6.4M
Verkoop	-49M 663M
EPS	-0.049
Dividendrendement	1.95
Winstmarge	-0.963
Werknemers	18,150
EBITDA	-808K 48M

Aanbevelingen
By TipRanks
Aanbevelingen	Sell
12 Maanden Prognose	+4.47% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.95% 3.27%
Volgende Winsten	5 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	705M
Vorige openingsprijs	8.17
Vorige sluitingsprijs	7.79

Vestis Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 apr 2026, 23:17 UTC

Winsten

Samsung Forecasts Record First-Quarter Operating Profit

6 apr 2026, 23:00 UTC

Populaire aandelen

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr 2026, 22:13 UTC

Belangrijke Marktbewegers

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr 2026, 21:46 UTC

Acquisities, Fusies, Overnames

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr 2026, 17:09 UTC

Belangrijke Marktbewegers

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr 2026, 16:56 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr 2026, 14:47 UTC

Belangrijke Marktbewegers

Stereotaxis Shares Rise on FDA Clearance for Synchrony

6 apr 2026, 23:58 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr 2026, 23:36 UTC

Marktinformatie

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr 2026, 23:15 UTC

Marktinformatie

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr 2026, 22:52 UTC

Marktinformatie

Global Equities Roundup: Market Talk

6 apr 2026, 22:52 UTC

Marktinformatie

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr 2026, 22:14 UTC

Marktinformatie

Correction to Live Cattle Futures Article

6 apr 2026, 20:56 UTC

Marktinformatie

Mexican Private Consumption Fell in January -- Market Talk

6 apr 2026, 20:50 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

6 apr 2026, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

6 apr 2026, 19:58 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

6 apr 2026, 19:58 UTC

Marktinformatie

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr 2026, 19:11 UTC

Marktinformatie

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr 2026, 19:06 UTC

Marktinformatie

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr 2026, 19:03 UTC

Marktinformatie

Global Energy Roundup: Market Talk

6 apr 2026, 19:03 UTC

Marktinformatie

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr 2026, 18:36 UTC

Acquisities, Fusies, Overnames

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr 2026, 17:59 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr 2026, 17:13 UTC

Acquisities, Fusies, Overnames

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr 2026, 16:33 UTC

Marktinformatie

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr 2026, 16:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

6 apr 2026, 14:59 UTC

Winsten

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

6 apr 2026, 14:20 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

High Bar Seen for Bank of Canada to Lift Rates Despite Oil's Spike -- Market Talk

Peer Vergelijking

Prijswijziging

Vestis Corp Prognose

Koersdoel

By TipRanks

4.47% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 8.18 USD 4.47%

Hoogste 10 USD

Laagste 6 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Vestis Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

7 ratings

Buy

Hold

Sell

Gebaseerd op 7 analisten die aandelenratings hebben gegeven aan Vestis Corp - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Andere aandelen uit de sector

Home Depot Inc.

326.25

↑ +1.37%

TJX

TJX Companies Inc.

161.61

↑ +0.19%

LOW

Lowe's Cos Inc

235.26

↑ +1.64%

ROST

Ross Stores Inc

220.93

↑ +0.46%

AZO

AutoZone Inc

3,438.06

↑ +1.18%

Vestis Corp

Overzicht

Wijziging aandelenprijs

Belangrijke statistieken

Aanbevelingen

Dividenden

Marktinformatie

Vestis Corp Grafiek

Gerelateerd nieuws

Peer Vergelijking

Vestis Corp Prognose

Koersdoel

Beoordelingsconsensus

Financieel

Andere aandelen uit de sector